Sigma-Aldrich to distribute BioLife's HypoThermosol and CryoStor biopreservation media products

NewsGuard 100/100 Score

BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that Sigma-Aldrich(R) will distribute the Company's proprietary HypoThermosol and CryoStor biopreservation media products under the terms of a non-exclusive distribution agreement.

Mike Rice, BioLife's chairman and CEO, noted, "We're pleased to have Sigma-Aldrich as a distribution partner for our biopreservation media products in the academic and clinical research markets. Clinical research customers voiced a need for better cell preservation media that did not include serum or protein components, and the value proposition of our HypoThermosol and CryoStor products aligned perfectly with this requirement. Our products are not only serum-free and protein-free, but are also manufactured under GMP in our Bothell production facility using only USP or highest available grade components. We are pleased to offer the research community fully defined, pre-formulated biopreservation media that improves post-preservation cell viability, recovery, and function."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study highlights how age affects nasal cell response to SARS-CoV-2